José Daniel Subiela Henríquez

22PUBLICATIONS
100CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 13, 2026
Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma.

|Apr 10, 2026
Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.

Patricia Willisch, Beatriz Vázquez-Barreiro, Ana Plata

|Mar 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Aleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri

|Mar 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Roberto Contieri, Alberto Martini, Marc Furrer

|Mar 03, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina

|Feb 26, 2026
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer.

Pietro Scilipoti, Paolo Zaurito, Mattia Longoni

Pageof 4

Frequent Collaborators

10 joint publications

Francesco Soria

9 joint publications

Renate Pichler

9 joint publications

Francesco Del Giudice

8 joint publications

Roberto Contieri